1 – 10 of 15
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Late Adverse Effects after Treatment for Childhood Acute Leukemia
(
- Contribution to journal › Scientific review
-
Mark
Risk of subsequent gliomas and meningiomas among 69,460 5-year survivors of childhood and adolescent cancer in Europe : the PanCareSurFup study
(
- Contribution to journal › Article
- 2023
-
Mark
Palliative care services in paediatric oncology centres across Europe : A cross-sectional survey
(
- Contribution to journal › Article
-
Mark
Risk of subsequent primary lymphoma in a cohort of 69,460 five-year survivors of childhood and adolescent cancer in Europe : The PanCareSurFup study
(
- Contribution to journal › Article
-
Mark
Risk of subsequent primary oral cancer in a cohort of 69,460 5-year survivors of childhood and adolescent cancer in Europe : the PanCareSurFup study
(
- Contribution to journal › Article
-
Mark
Risk Factors for Primary Bone Cancer After Childhood Cancer : A PanCare Childhood and Adolescent Cancer Survivor Care and Follow-Up Studies Nested Case-Control Study
2023) In Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41(21). p.3735-3746(
- Contribution to journal › Article
- 2022
-
Mark
Evaluating the feasibility, effectiveness and costs of implementing person-centred follow-up care for childhood cancer survivors in four European countries : the PanCareFollowUp Care prospective cohort study protocol
(
- Contribution to journal › Article
-
Mark
The PanCareFollowUp Care Intervention : A European harmonised approach to person-centred guideline-based survivorship care after childhood, adolescent and young adult cancer
(
- Contribution to journal › Article
-
Mark
Childhood cancer survivorship care during the COVID-19 pandemic : an international report of practice implications and provider concerns
(
- Contribution to journal › Article
- 2020
-
Mark
Guidance regarding COVID-19 for survivors of childhood, adolescent, and young adult cancer : A statement from the International Late Effects of Childhood Cancer Guideline Harmonization Group
(
- Contribution to journal › Article